These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36297577)

  • 1. Aqueous Prostaglandin Eye Drop Formulations.
    Jansook P; Loftsson T
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297577
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M
    In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.
    Lusthaus JA; Goldberg I
    Expert Opin Emerg Drugs; 2016; 21(1):117-28. PubMed ID: 26854598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.
    Lee AJ; McCluskey P
    Clin Ophthalmol; 2010 Jul; 4():741-64. PubMed ID: 20689791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.
    Asrani S; Bacharach J; Holland E; McKee H; Sheng H; Lewis RA; Kopczynski CC; Heah T
    Adv Ther; 2020 Apr; 37(4):1620-1631. PubMed ID: 32166538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of glaucoma: focus on pharmacological therapy.
    Marquis RE; Whitson JT
    Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering combination therapies with prostaglandin analogues.
    Aptel F; Chiquet C; Romanet JP
    Drugs; 2012 Jul; 72(10):1355-71. PubMed ID: 22686588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.
    Sharif NA
    Front Pharmacol; 2021; 12():729249. PubMed ID: 34603044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ab interno trabecular bypass surgery with iStent for open-angle glaucoma.
    Le JT; Bicket AK; Wang L; Li T
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012743. PubMed ID: 30919929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
    Stankowska DL; Millar JC; Kodati B; Behera S; Chaphalkar RM; Nguyen T; Nguyen KT; Krishnamoorthy RR; Ellis DZ; Acharya S
    Mol Vis; 2021; 27():37-49. PubMed ID: 33633438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.
    Aptel F; Denis P
    Curr Med Res Opin; 2011 Oct; 27(10):1949-58. PubMed ID: 21878000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.
    Sanford M
    Clin Drug Investig; 2014 Jul; 34(7):521-8. PubMed ID: 24895141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy.
    Liu AW; Gan LY; Yao X; Zhou J
    Int J Ophthalmol; 2016; 9(5):750-6. PubMed ID: 27275435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.
    Liu Y; Zhao J; Zhong X; Wei Q; Huang Y
    Front Pharmacol; 2019; 10():679. PubMed ID: 31293419
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China.
    Sun X; Liu Q; Tang X; Yao K; Li Y; Yang J; Zhang M; Yuan H; Zheng Y; Li W; Peng H
    BMC Ophthalmol; 2022 Aug; 22(1):332. PubMed ID: 35932001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
    Millar JC; Savinainen A; Josiah S; Pang IH
    Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.
    Li F; Huang W; Zhang X
    Acta Ophthalmol; 2018 May; 96(3):e277-e284. PubMed ID: 29144028
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.